|
⚲
|
| Keyboard |
| Topper David Joseph
✚
|
|
|---|---|
| CIK # | 0001740378 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001740378] | |
| 4 | [0001740378] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Arcutis Biotherapeutics Inc | |
| Topper David Joseph | |
| Frazier Lifesciences Acquisition Corp | |
| Engility Holdings Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Arcutis Biotherapeutics Inc ARQT
Common Stock
|
2025-04-02 | Sell | 9,600 | $15.80 | 151,680 |
|
Arcutis Biotherapeutics Inc ARQT
Common Stock
|
2025-02-28 | Grant | 34,000 | $0.00 | |
|
Arcutis Biotherapeutics Inc ARQT
Stock Option (right to buy) · derivative
|
2025-02-28 | Grant | 89,000 | $0.00 | |
|
Arcutis Biotherapeutics Inc ARQT
Common Stock
|
2024-09-24 | Sell | 11,626 | $9.48 | 110,214 |
|
Arcutis Biotherapeutics Inc ARQT
Common Stock
|
2024-09-21 | Grant | 60,000 | $0.00 | |
|
Arcutis Biotherapeutics Inc ARQT
Stock Option (right to buy) · derivative
|
2024-04-10 | Grant | 310,000 | $0.00 | |
|
Arcutis Biotherapeutics Inc ARQT
Common Stock
|
2024-04-10 | Grant | 110,000 | $0.00 | |
|
Frazier Lifesciences Acquisition Corp FLAC
Class B Ordinary Shares · derivative
|
2022-11-22 | Option exercise | 30,000 | ||
|
Engility Holdings Inc EGL
Common Stock
|
2019-01-14 | Disposed to issuer | 8,960,446 |